EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
AIIM Opens Call for Speakers for AI+IM Global Summit 2026
-
AIIM has opened its call for speakers for the AI+IM Global Summit 2026,
scheduled for April 28-30, 2026 in Baltimore, MD. There are no restrictions
on who ...
6 days ago
No comments:
Post a Comment